View |
|
DRP-48946
|
Multivitamins + Minerals
|
Nutiplete
|
Formulation
Each Tablet contains:
Ascorbic Acid (Vitamin C)
dl-alpha Tocopheryl (as acetate) (Vitamin E)
200 mg 50 IU
Manganese (as sulfate monohydrate)
3 mg
Copper (as cupric oxide)
1 mg
Beta Carotene (Vitamin A)
2000 IU
Vitamin Ki
75 mcg
Selenium (as sodium selenite) Zinc (as zinc oxide)
70 mcg
15 mcg
|
Tablet
|
Vitamins/Minerals
|
The Acme Laboratories Ltd.
|
Bangladesh
|
Initial (Correction)
|
26 September 2024
|
09 January 2029
|
View |
|
DRHR-2315
|
Benzydamine (as hydrochloride)
|
Difflam Lemon
|
3mg
|
Lozenges
|
Throat Preparation
|
Unique Pharmaceuticals Laboratories (Division of
J.B. Chemicals & Pharmaceuticals Ltd.)
|
Singapore
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14731
|
Paracetamol
|
Pyromed
|
120mg/5mL
|
Syrup
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14730
|
Paracetamol
|
Pyromed Kids
|
250 mg/5 mL
|
Syrup (Raspberry Flavor)
|
Analgesic/Antipyretic
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14729
|
Ascorbic Acid + Zinc + Cholecalciferol
|
Sydend3 Pluz
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/ 10 mg (equivalent to 27.45 mg Zinc Sulfate Monohydrate)/1000 IU
|
Capsule
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial
|
29 January 2024
|
09 January 2029
|
View |
|
DRP-14770
|
Olmesartan Medoxomil + Amlodipine (as besilate)
|
Amlopril
|
20 mg/5 mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14769
|
Olmesartan Medoxomil + Amlodipine (as besilate)
|
Amlopril
|
40 mg/5 mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14791
|
Moxifloxacin (as
Hydrochloride)
|
Moxidrop
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Skymap Healthcare Pvt. Ltd.
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14768
|
Olmesartan Medoxomil + Amlodipine (as besilate)
|
Amlopril
|
40 mg/ 10 mg
|
Film Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
09 January 2024
|
09 January 2029
|
View |
|
DRP-14696
|
Dexamethasone Phosphate (As Sodium)
|
Dexago
|
4 mg/mL (8 mg/2 mL)
|
Solution for Injection (I.V./I/M.)
|
Corticosteroid
|
Makcur Laboratories Limited
|
India
|
Initial
|
10 January 2024
|
10 January 2029
|
View |
|
DRP-14799
|
Multivitamins
|
Ebavit
|
Formulation
Each capsule contains:
Retinol acetate (Vitamin A) 1750 IU (equivalent to 525 meg of Retinol Acetate)
Cholecalciferol (Vitamin D3) 400 IU (equivalent to 10 mg of Cholecalciferol)
DI-Alpha Tocopheryl Acetate (Vitamin E) 10 IU (equivalent to 10 mg of DI-Alpha Tocopheryl Acetate)
Ascorbic Acid (Vitamin C) 80 mg
Niacinamide (Vitamin B3) 20 mg
Pyridoxine hydrochloride (Vitamin B6) 2 mg
Thiamine mononitrate (Vitamin B1) 1.30 mg
Riboflavin (Vitamin B2) 130mg
Folic Acid (Vitamin B9) 170 mcg
Cyanocobalamin (Vitamin B12) 5 mcg
|
Capsule
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2024
|
10 January 2029
|
View |
|
DRP-14800
|
Multivitamins + Minerals
|
Ebaminvit
|
Formulation
Each film-coated tablet contains.
Retinol acetate (Vitamin A) 5,000 IU (equivalent to 10 mg of Retinol Acetate)
Cholecalciferol (Vitamin D3) 400 IU (equivalent to 4 mg of Cholecalciferol)
d-Alpha Tocopherol (Vitamin E) 10 IU (equivalent to 14.29 mg of d-Alpha Tocopherol}
Ascorbic Acid (Vitamin C) 50 mg
Nicotinamide 20 mg
Calcium Pantothenate 5 mg
Thiamine mononitrate (Vitamin B1) 2.50 mg
Riboflavin (Vitamin B2) 2.50 mg
Pyridoxine hydrochloride (Vitamin B6) 500 mcg
Cyanocobalamin (Vitamin B12) 2 mcg
Calcium 35 mg (equivalent to 87 50 mg Calcium Carbonate)
Iron 10 mg (equivalent to 30 mg Ferrous Fumarate)
Magnesium 6 mg (equivalent to 20 82 mg Magnesium Carbonate)
Potassium 5 mg (equivalent to 9.55 mg Potassium Chloride)
Manganese 1 mg (equivalent to 3.076 mg Manganese Sulfate Monohydrate)
|
Film-Coated Tablet
|
Vitamin/ Mineral
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2024
|
10 January 2029
|
View |
|
DRP-14801
|
Rasagiline (as mesilate)
|
Relzin
|
1 mg
|
Tablet
|
Anti-Parkinson Drug (Monoamine Oxidase B Inhibitor)
|
Zydus Lifesciences Limited
|
India
|
Initial
|
11 January 2024
|
11 January 2029
|
View |
|
DR-XY48976
|
Dolutegravir (as sodium) + Lamivudine + Tenofovir
Disoproxil (as fumarate)
|
None
|
50 mg/300 mg/300 mg
|
Film-Coated Tablet
|
Direct Acting Antiviral
|
Aurobindo Pharma Limited -Unit X
|
India
|
Monitored release
|
10 January 2024
|
10 January 2029
|
View |
|
DR-XY48974
|
Roflumilast
|
Rolfutor 500
|
500 mcg
|
Tablet
|
Drug for Obstructive Airway Diseases
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
11 January 2024
|
11 January 2029
|
View |
|
DRP-14802
|
Ondansetron (as hydrochloride dihydrate)
|
Ondero
|
2 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Antagonist]
|
Aspiro Pharma Limited
|
India
|
Initial
|
11 January 2024
|
11 January 2029
|
View |
|
DR-XY48975
|
Rosuvastatin (as calcium)
|
Rovastin
|
20 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Hizon Laboratories, Inc.
|
Philippines
|
Initial
|
11 January 2024
|
11 January 2029
|
View |
|
DR-XY48953
|
Ferrous sulfate + Folic acid
|
None
|
200 mg (equivalent to 60 mg elemental Iron) 400 mcg
|
Film-Coated Tablet
|
Anti-Anemic
|
Medicamen Organics Limited (Unit 1)
|
India
|
Initial
|
11 January 2024
|
11 January 2029
|
View |
|
DRP-14803
|
Ketoconazole
|
Novazol
|
20 mg/g (2% w/w)
|
Cream
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
Initial [OTCI]
|
11 January 2024
|
11 January 2029
|
View |
|
DRP-14807
|
Irinotecan Hydrochloride (as trihydrate)
|
None
|
20 mg/mL (100 mg/5 mL)
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Shilpa Medicare Limited (Unit-4, Pharmaceutical
Formulations Sez)
|
India
|
Initial
|
12 January 2024
|
12 January 2029
|